BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3992100)

  • 1. [Ambulatory noradrenaline infusion in refractory Shy-Drager syndrome].
    Kribben A; Fritschka E; Philipp T; Thiede HM; Distler A
    Schweiz Rundsch Med Prax; 1985 Apr; 74(16):407-10. PubMed ID: 3992100
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory infusion of noradrenaline for long-term treatment of Shy-Drager syndrome.
    Kribben A; Bremer C; Fritschka E; Koeppen S; Ahrens O; Philipp T
    Kidney Blood Press Res; 1998; 21(1):70-3. PubMed ID: 9661140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Shy-Drager syndrome].
    Huang HF
    Zhonghua Nei Ke Za Zhi; 1984 Sep; 23(9):569-71. PubMed ID: 6532705
    [No Abstract]   [Full Text] [Related]  

  • 5. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).
    West JN; Stallard TJ; Dimmitt SB; Smith SA; Williams A; Littler WA
    Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin and propranolol combined treatment for Shy-Drager syndrome.
    Galassi G
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Shy-Drager syndrome: description of a clinical case which failed to respond to propranolol, ergotamine and indomethacin].
    Rodríguez Vallejo A; Shamdas GJ; Palacios J; Morales MA; Antigüedad A; Hernández J; Portera A
    Arch Neurobiol (Madr); 1986; 49(1):46-53. PubMed ID: 3707267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acetylsalicylic acid and indomethacin in the treatment of idiopathic orthostatic hypotension and Shy-Drager's syndrome].
    Hinge HH; Mikkelsen B; Korsager S
    Ugeskr Laeger; 1985 Apr; 147(14):1196-8. PubMed ID: 4002380
    [No Abstract]   [Full Text] [Related]  

  • 9. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postganglionic noradrenergic nervous function in Shy-Drager syndrome].
    Araki N; Gotoh F; Komatsumoto S; Gomi S; Hamada J
    Rinsho Shinkeigaku; 1988 Oct; 28(10):1156-63. PubMed ID: 3219805
    [No Abstract]   [Full Text] [Related]  

  • 11. Shy-Drager syndrome.
    Huang HF; Guo YP; Feng YK
    Chin Med J (Engl); 1982 Sep; 95(9):679-86. PubMed ID: 6817994
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular manifestations of Shy-Drager syndrome.
    Nirankari VS; Khurana RK; Lakhanpal V
    Ann Ophthalmol; 1982 Jul; 14(7):635-8. PubMed ID: 6127047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Shy-Drager disease. Apropos of 5 cases including 1 with anatomical study].
    Leys D; Destee A; Petit H; Warot P
    LARC Med; 1983 Oct; 3(8):531-4. PubMed ID: 6664190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome].
    Irace L; Lus G; Spadaro P; Ducceschi V; De Marco N; Sarubbi B; Iacono A; Cotrufo R
    Cardiologia; 1994 Nov; 39(11):797-802. PubMed ID: 7736480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
    Rae-Grant A; Young GB; Spence JD
    Neurology; 1985 Jul; 35(7):1085-6. PubMed ID: 4010957
    [No Abstract]   [Full Text] [Related]  

  • 16. [Shy-Drager syndrome: report of a personal clinical experience].
    Carapezzi C; Chesi G; Di Donato C; Prandi G; Marani L
    G Clin Med; 1983; 64(7-8):257-68. PubMed ID: 6642109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of the Shy-Drager syndrome].
    Philipp T; Kribben A; Fritschka E
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1942-3. PubMed ID: 4075989
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and treatment of Shy-Drager syndrome].
    Gubskiĭ LV
    Sov Med; 1989; (6):115-7. PubMed ID: 2799483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulatory disturbance of Shy-Drager syndrome--nocturnal polygraphic study (author's transl)].
    Koike Y; Hibino R; Motegi Y; Hashizume M; Sobue I
    Rinsho Shinkeigaku; 1981 Nov; 21(11):944-51. PubMed ID: 7333052
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma catecholamines during activation of the sympathetic nervous system in a patient with Shy-Drager syndrome.
    Gross G; Nagel-Hiemke M; Krause KH
    J Neurol; 1980; 224(2):125-31. PubMed ID: 6160216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.